Top news from MedWatch this week
![Photo: MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/13909766/ez4a7p/ALTERNATES/schema-16_9/doc7kh6gc8orsnaiyui1vg.jpg)
Mandag
Deborah Dunsire steps down as CEO of Lundbeck
Lundbeck chair confirms: Deborah Dunsire was dismissed
Deborah Dunsire leaves Lundbeck after five years with one launch and a more padded pipeline
Lilly’s Mounjaro gives positive results in obese diabetic people
Eli Lilly boasts big weight-loss in study of GLP-1 tablet
Tuesday
Lundbeck board denies debated bonus scheme for incoming CEO
Lundbeck chair points to incoming CEO’s biggest challenge: patent expiration
Jefferies: Eli Lilly shows ”noteworthy” weight reduction with next-generation obesity drug
Bavarian Nordic: Covid vaccine unlikely to be approved based on primary endpoints
Wednesday
GN inks divestment agreement in Portugal
Genmab and AbbVie present positive topline data from cancer drug trial in new indication
Analyst: Epcoritamab topline data is quite impressive
Thursday
Eli Lilly to acquire diabetes-focused biotech company
Fujifilm Diosynth Biotechnologies appoints COO as CEO
Competition council forces Coloplast to adjust prices in Denmark
Friday
Novo to focus more on the US: Europe is already ten years behind